Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.
about
Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free BeamsClinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.Stereotactic radiotherapy for early stage non-small cell lung cancerFocal exposure of limited lung volumes to high-dose irradiation down-regulated organ development-related functions and up-regulated the immune response in mouse pulmonary tissues.Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy.Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancerImpacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer.Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy.Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.[Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer].
P2860
Q29248456-E24F3E6E-B4CE-4F38-A631-395165E4DF3DQ30834087-4176FB97-3702-4738-BA11-1687E83589E1Q35824255-1EDA4257-BB3B-4313-B575-C1B4B4B374D3Q35906384-63EDCBA4-7DD6-4D47-ABD2-5F79BF46D406Q35907834-952A530B-D562-4F85-B629-A4B46303B688Q36363955-5F4A1A20-ACEE-40A5-81CF-0FE0D26D8BB6Q36550894-7E7D133E-EFF8-4459-9370-F87FF82F2865Q37458027-2C44244E-760A-4CB8-BE8D-73CF749C7FCBQ37670436-68ABC419-E332-4D5D-9984-7339CB4501BCQ38705654-1CD008AD-5B19-46D6-97E4-D1531C0A7E4FQ40266925-1C320681-5D47-49D0-9E65-C98D75881F3BQ41431618-6CC57929-24A2-453C-A3DF-7E3A36B7CB94Q50578610-967C6465-0BB8-4356-A11A-88CF93A03BFFQ51621075-31243D4A-DB87-4AD8-8BA8-C233C4C1A05EQ55441727-EF93DFBC-4B9A-4789-96C5-75EACB8A2545
P2860
Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@ast
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@en
type
label
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@ast
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@en
prefLabel
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@ast
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@en
P2093
P50
P1476
Predictive parameters of sympt ...... ing volumetric modulated arcs.
@en
P2093
Andrew Warner
Cornelis J A Haasbeek
David A Palma
Eva M Bongers
Wilko F A R Verbakel
P356
10.1016/J.RADONC.2013.10.011
P577
2013-10-31T00:00:00Z